Effects of aging and hypercholesterolemia on oxidative stress and DNA damage in bone marrow mononuclear cells in apolipoprotein E-deficient mice

International Journal of Molecular Sciences

Volumn 14, Issue 2, 2013, Pages 3325-3342

  Tonini, Clarissa L ^a   Campagnaro, Bianca P ^a   Louro, Lis P S ^a   Pereira, Thiago M C ^b,c   Vasquez, Elisardo C ^a,d   Meyrelles, Silvana S ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Federal Institute of Education   (Brazil)

^c UNIVERSIDADE VILA VELHA   (Brazil)

^d Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

Apolipoprotein E; Comet assay; DNA damage; Genotoxicity; Oxidative stress

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; GLUCOSE; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW CELL; CELL AGING; CHOLESTEROL BLOOD LEVEL; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; FLOW CYTOMETRY; FLUID INTAKE; GENOTOXICITY; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; LIPID STORAGE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEFICIENCY; TISSUE REPAIR; WEIGHT GAIN;

EID: 84875121531     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14023325     Document Type: Article

References (66)

1. Ross, R. Atherosclerosis--an inflammatory disease. N. Engl. J. Med. 1999, 340, 115-126.
2. Vasquez, E.C.; Peotta, V.A.; Gava, A.L.; Pereira, T.M.; Meyrelles, S.S. Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse. J. Biomed. Sci. 2012, 19, doi:10.1186/1423-0127-19-22.
3. Marnett, L.J. Oxyradicals and DNA damage. Carcinogenesis 2003, 21, 361-370.
4. Bauer, V.; Sotníková, R.; Drábiková, K. Effects of reactive oxygen species and neutrophils on endothelium-dependent relaxation of rat thoracic aorta. Interdiscip. Toxicol. 2011, 4, 191-197.
5. McEwen, J.E.; Zimniak, P.; Mehta, J.L.; Shmookler Reis, R.J. Molecular pathology of aging and its implications for senescent coronary atherosclerosis. Curr. Opin. Cardiol. 2005, 20, 399-406.
6. Madamanchi, N.R.; Runge, M.S. Mitochondrial dysfunction in atherosclerosis. Circ. Res. 2007, 100, 460-473.
7. Zhang, X.; Qi, R.; Xian, X.; Yang, F.; Blackstein, M.; Deng, X.; Fan, J.; Ross, C.; Karasinska, J.; Hayden, M.R.; et al. Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet. Circ. Res. 2008, 102, 250-256.
8. Collins, A.R.; Lyon, C.J.; Xia, X.; Liu, J.Z.; Tangirala, R.K.; Yin, F.; Boyadjian, R.; Bikineyeva, A.; Praticò, D.; Harrison, D.G.; et al. Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ. Res. 2009, 104, e42-e54.
9. Hasty, P.; Campisi, J.; Hoeijmakers, J.; van Steeg, H.; Vijg, J. Aging and genome maintenance: lessons from the mouse? Science 2003, 299, 1355-1359.
10. Kregel, K.C.; Zhang, H.J. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292, R18-R36.
11. Vasquez, E.C.; Peotta, V.A.; Meyrelles, S.S. Cardiovascular autonomic imbalance and baroreflex dysfunction in the apolipoprotein E-deficient mouse. Cell Physiol. Biochem. 2012, 29, 635-646.
12. Pereira, T.M.; Nogueira, B.V.; Lima, L.C.; Porto, M.L.; Arruda, J.A.; Vasquez, E.C.; Meyrelles, S.S. Cardiac and vascular changes in elderly atherosclerotic mice: The influence of gender. Lipids Health Dis. 2010, 9, 87.
13. Porto, M.L.; Lima, L.C.; Pereira, T.M.; Nogueira, B.V.; Tonini, C.L.; Campagnaro, B.P.; Meyrelles, S.S.; Vasquez, E.C. Mononuclear cell therapy attenuates atherosclerosis in apoE KO mice. Lipids Health. Dis. 2011, 10, 155.
14. Lima, L.C.; Porto, M.L.; Campagnaro, B.P.; Tonini, C.L.; Nogueira, B.V.; Pereira, T.M.; Vasquez, E.C.; Meyrelles, S.S. Mononuclear cell therapy reverts cuff-induced thrombosis in apolipoprotein E-deficient mice. Lipids Health. Dis. 2012, 11, 96.
15. Meyrelles, S.S.; Peotta, V.A.; Pereira, T.M.; Vasquez, E.C. Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Lipids Health Dis. 2011, 10, 211.
16. Folkmann, J.K.; Loft, S.; Møller, P. Oxidatively damaged DNA in aging dyslipidemic apoE-/-and wild-type mice. Mutagenesis 2007, 22, 105-110.
17. Dalboni, S.P.; Campagnaro, B.P.; Tonini, C.L.; Vasquez, E.C.; Meyrelles, S.S. The concurrence of hypercholesterolemia and aging promotes DNA damage in apolipoprotein E-deficient mice. Open J. Blood Dis. 2012, 2, 51-55.
18. Cuende, N.; Rico, L.; Herrera, C. Bone marrow mononuclear cells for the treatment of ischemic syndromes: medicinal product or cell transplantation? Stem Cells Trans. Med. 2012, 1, 403-408.
19. Campagnaro, B.P.; Gava, A.L.; Meyrelles, S.S.; Vasquez, E.C. Cardiac-autonomic imbalance and baroreflex dysfunction in the renovascular angiotensin-dependent hypertensive mouse. Int. J. Hypertens. 2012, 2012, doi:10.1155/2012/968123.
20. Nakashima, Y.; Plump, A.S.; Raines, E.W.; Breslow, J.L.; Ross, R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. Vasc. Biol. 1994, 14, 133-140.
21. Reddick, R.L.; Zhang, S.H.; Maeda, N. Atherosclerosis in mice lacking apo E: evaluation of lesional development and progression. Arterioscler. Thromb. Vasc. Biol. 1994, 14, 141-147.
22. Zhang, S.H.; Reddick, R.L.; Piedrahita, J.A.; Maeda, N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258, 468-471.
23. Jawień, J.; Nastałek, P.; Korbut, R. Mouse models of experimental atherosclerosis. J. Physiol. Pharmacol. 2004, 55, 503-517.
24. Goldschmidt-Clermont, P.J. Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis. Am. Heart J. 2003, 146, S5-S12.
25. Kojda, G.; Harrison, D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc. Res. 1999, 43, 562-571.
26. Groemping, Y.; Rittinger, K. Activation and assembly of the NADPH oxidase: A structural perspective. Biochem. J. 2005, 386, 401-416.
27. Ballinger, S.W. Mitochondrial dysfunction in cardiovascular disease. Free Radic. Biol. Med. 2005, 38, 1278-1295.
28. Dikalov, S. Crosstalk between mitochondria and NADPH oxidases. Free Radic. Biol. Med. 2011, 51, 1289-1301.
29. Schröder, K.; Vecchione, C.; Jung, O.; Schreiber, J.G.; Shiri-Sverdlov, R.; van Gorp, P.J.; Busse, R.; Brandes, R.P. Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet. Free Radic. Biol. Med. 2006, 41, 1353-1360.
30. Takaya, T.; Hirata, K.; Yamashita, T.; Shinohara, M.; Sasaki, N.; Inoue, N.; Yada, T.; Goto, M.; Fukatsu, A.; Hayashi, T.; et al. A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1632-1637.
31. Jawien, J.; Gajda, M.; Wołkow, P.; Zurańska, J.; Olszanecki, R.; Korbut, R. The effect of montelukast on atherogenesis in apoE/LDLR-double knockout mice. J. Physiol. Pharmacol. 2008, 59, 633-639.
32. Sheehan, A.L.; Carrell, S.; Johnson, B.; Stanic, B.; Banfi, B.; Miller, F.J., Jr. Role for Nox1 NADPH oxidase in atherosclerosis. Atherosclerosis 2011, 216, 321-326.
33. Zou, H.; Stoppani, E.; Volonte, D.; Galbiati, F. Caveolin-1, cellular senescence and age-related diseases. Mech. Ageing. Dev. 2001, 132, 533-542.
34. Law, A.; Gauthier, S.; Quirion, R. Alteration of nitric oxide synthase activity in young and aged apolipoprotein E-deficient mice. Neurobiol. Aging 2003, 24, 187-190.
35. Jiang, F.; Jones, G.T.; Dusting, G.J. Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein (E)-deficient mice. Br. J. Pharmacol. 2007, 152, 880-890.
36. Matthews, C.; Gorenne, I.; Scott, S.; Figg, N.; Kirkpatrick, P.; Ritchie, A.; Goddard, M.; Bennett, M. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ. Res. 2006, 99, 156-164.
37. Tatarková, Z.; Kuka, S.; Račay, P.; Lehotský, J.; Dobrota, D.; Mištuna, D.; Kaplán, P. Effects of aging on activities of mitochondrial electron transport chain complexes and oxidative damage in rat heart. Physiol. Res. 2011, 60, 281-289.
38. Wang, J.C.; Bennett, M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ. Res. 2012, 111, 245-259.
39. Evans, M.D.; Dizdaroglu, M.; Cooke, M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 2004, 567, 1-61.
40. Ellahueñe, M.F.; Pérez-Alzola, L.P.; Farfán-Urzua, M.; González-Hormazabal, P.; Garay, M.; Olmedo, M.I.; Last, J.A. Preliminary evaluation of DNA damage related with the smoking habit measured by the comet assay in whole blood cells. Cancer Epidemiol. Biomark. Prev. 2004, 13, 1223-1229.
41. Singh, N.P.; McCoy, M.T.; Tice, R.R.; Schneider, E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175, 184-191.
42. Lee, R.F.; Steinert, S. Use of the single cell gel electrophoresis/comet assay for detecting DNA damage in aquatic (marine and freshwater) animals. Mutat. Res. 2003, 544, 43-64.
43. Yao, Y.; Tian, X.; Liu, X.; Shao, J.; Lv, Y. The p53-mediated apoptosis in hypercholesterolemiainduced renal injury of rats. J. Huazhong. Univ. Sci. Technol. Med. Sci. 2005, 25, 408-411.
44. Sevin, G.; Yasa, M.; Akcay, D.Y.; Kirkali, G.; Kerry, Z. Different responses of fluvastatin to cholesterol-induced oxidative modifications in rabbits: evidence for preventive effect against DNA damage. Cell Biochem. Funct. 2012, 38, 1278-1295.
45. Martinet, W.; Knaapen, M.W.; De Meyer, G.R.; Herman, A.G.; Kockx, M.M. Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ. Res. 2001, 88, 733-739.
46. Ronsein, G.E.; de Oliveira, M.C.; Medeiros, M.H.; Miyamoto, S.; Di Mascio, P. DNA strand breaks and base modifications induced by cholesterol hydroperoxides. Free. Radic. Res. 2011, 45, 266-275.
47. Polyak, K.; Xia, Y.; Zweier, J.L.; Kinzler, K.W.; Vogelstein, B. A model for p53-induced apoptosis. Nature 1997, 389, 300-305.
48. Mercer, J.; Mahmoudi, M.; Bennett, M. DNA damage, p53, apoptosis and vascular disease. Mutat. Res. 2007, 621, 75-86.
49. Mercer, J.R.; Cheng, K.K.; Figg, N.; Gorenne, I.; Mahmoudi, M.; Griffin, J.; Vidal-Puig, A.; Logan, A.; Murphy, M.P.; Bennett, M. DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ. Res. 2010, 107, 1021-1031.
50. Yu, E.; Mercer, J.; Bennett, M. Mitochondria in vascular disease. Cardiovasc. Res. 2012, 95, 173-182.
51. Shaposhnikov, S.; Larsson, C.; Henriksson, S.; Collins, A.; Nilsson, N. Detection of Alu sequences and mtDNA in comets using padlock probes. Mutagenesis 2006, 21, 243-247.
52. Harman, D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11, 298-300.
53. Clutton, S. The importance of oxidative stress in apoptosis. Br. Med. Bull. 1997, 53, 662-668.
54. Berlett, B.S.; Stadtman, E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 1997, 272, 20313-20316.
55. Slater, T.F. Free radicals and tissue injury: fact and fiction. Br. J. Cancer. Suppl. 1987, 8, 5-10.
56. Simon, H.U.; Haj-Yehia, A.; Levi-Schaffer, F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000, 5, 415-418.
57. Spiteller, G. The relation of lipid peroxidation processes with atherogenesis: A new theory on atherogenesis. Mol. Nutr. Food Res. 2005, 49, 999-1013.
58. Bayir, H.; Kagan, V.E. Bench-to-bedside review: Mitochondrial injury, oxidative stress and apoptosis--there is nothing more practical than a good theory. Crit. Care. 2008, 12, 206.
59. Papaharalambus, C.A.; Griendling, K.K. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends. Cardiovasc. Med. 2007, 17, 48-54.
60. Devlin, A.M.; Clark, J.S.; Reid, J.L.; Dominiczak, A.F. DNA synthesis and apoptosis in smooth muscle cells from a model of genetic hypertension. Hypertension 2000, 36, 110-115.
61. Rauscher, F.M.; Goldschmidt-Clermont, P.J.; Davis, B.H.; Wang, T.; Gregg, D.; Ramaswami, P.; Pippen, A.M.; Annex, B.H.; Dong, C.; Taylor, D.A. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003, 108, 457-463.
62. Thorin-Trescases, N.; Voghel, G.; Gendron, M.E.; Krummen, S.; Farhat, N.; Drouin, A.; Perrault, L.P.; Thorin, E. Pathological aging of the vascular endothelium: are endothelial progenitor cells the sentinels of the cardiovascular system? Can. J. Cardiol. 2005, 21, 1019-1024.
63. Goldschmidt-Clermont, P.J.; Seo, D.M.; Wang, L.; Beecham, G.W.; Liu, Z.J.; Vazquez-Padron, R.I.; Dong, C.; Hare, J.M.; Kapiloff, M.S.; Bishopric, N.H.; et al. Inflammation, stem cells and atherosclerosis genetics. Curr. Opin. Mol. Ther. 2010, 12, 712-723.
64. Dauwe, D.F.; Janssens, S.P. Stem cell therapy for the treatment of myocardial infarction. Curr. Pharm. Des. 2011, 17, 3328-3340.
65. Strauer, B.E.; Steinhoff, G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J. Am. Coll. Cardiol. 2011, 58, 1095-1104.
66. Feng, Y.; Yang, S.H.; Xiao, B.J.; Xu, W.H.; Ye, S.N.; Xia, T.; Zheng, D.; Liu, X.Z.; Liao, Y.F. Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head. Bone 2010, 46, 32-40.